CABG and PCI Comparable in ACS Patients With Left Main CAD
The results line up with an all-comers analysis and point to an evolving understanding of how to treat LM CAD, say experts.
Source: tctmd.com
Stay updated with breaking news from Colin Baigent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The results line up with an all-comers analysis and point to an evolving understanding of how to treat LM CAD, say experts.
Doctors began to recommend that anyone over the age of 55 who worried they were at risk of a heart attack could opt to take the drug daily.
/PRNewswire/ -- EMPA-KIDNEY phase III clinical trial met its primary endpoint by demonstrating a significant kidney and cardiovascular benefit for adults...
New research suggests that side effects are caused by other factors, but some experts disagree.
The top 3 things you should know to start your day.